No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.
Authors: Carr A (AUTHOR), Workman C (AUTHOR), Carey D (AUTHOR), Rogers G (AUTHOR), Martin A (AUTHOR), Baker D (AUTHOR), Wand H (AUTHOR), Law M (AUTHOR), Samaras K (AUTHOR), Emery S (AUTHOR), Cooper DA (AUTHOR), Rosey Investigators (CORPORATE AUTHOR)
Source: Lancet. 2/7/2004, Vol. 363 Issue 9407, p429-438. 10p.
Database: Psychology and Behavioral Sciences Collection
Description
ISSN:01406736
DOI:10.1016/s0140-6736(04)15489-5